ClinicalTrials.gg
Not yet recruitingNCT07360613EFTERSUpdated Jan 22, 2026

Effect of Technology Enriched Rehabilitation After Stroke

An interventional study of Technology Enriched Rehabilitation in Stroke and Rehabilitation, sponsored by University of Strathclyde. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by University of Strathclyde · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The Biomedical Engineering Dept, University of Strathclyde, co-creates rehabilitation technology. In 2023-2024 a clinical study (NCT06787768) was conducted to understand the feasibility of a multi-technology approach to rehabilitation early after stroke. This was successful and leads to the next phase which is to gather preliminary evidence of the effectiveness of this approach by monitoring change in the mobility of patients who receive this intervention compared with usual care which will be gathered through a data linkage project (tracking the outcomes from matched patients from other parts of Scotland who receive usual care).

Read the detailed description

Rationale A well-established multi-disciplinary research group at the University of Strathclyde (UoS) Biomedical Engineering department have developed and tested a multi-technology rehabilitation model as a solution to the gap between clinical need and current provision. The technology enriched rehabilitation model has been tested under controlled conditions with chronic stroke survivors (at least one-year post stroke) and shown to be feasible with preliminary evidence of efficacy. The model has since been tested on acute/sub-acute stroke patients in an NHS stroke unit and found to be feasible and clinically acceptable with early evidence of an increased rehabilitation dose. This early stroke population has greater potential for recovery as the brain is more receptive to recovery through structural changes to neural pathways (neuroplasticity), therefore delivering higher intensity rehabilitation is therefore more critical at this phase of rehabilitation.

Funding has now been secured to progress this work by gathering evidence on the effectiveness of this approach in recovery mobility (walking, balance and) as well as gathering preliminary evidence of cost effectiveness (healthcare use).

Overall aim To determine whether early, technology-based rehabilitation after stroke improves mobility compared with usual care, using a virtual control group from national linked data, and to identify factors that influence recovery and assess economic benefit.

Specific questions;

  1. In sub-acute stroke, does technology-enhanced rehabilitation improve mobility (mRMI) versus a virtual usual-care control identified via a data linkage study, 3 and 6 months after stroke?
  2. What is the relationship between delivered dose (hours of rehabilitation) and outcome?
  3. Which baseline factors influence outcomes?
  4. What are the potential economic benefits of the technology-based rehabilitation programme compared with usual care, based on differences in healthcare and social care resource use and patient outcomes, using national linked data?

Outcome measures The primary variable for comparison will be the modified Rivermead Mobility Index (mRMI) which is a standard measure of mobility routinely used in the NHS, including NHS Lanarkshire. In addition to this the research team will carry out the following tests before the intervention and before discharge.

Measures of motor recovery:

10mwt, five times sit to stand, short version of the BERG Balance Scale, Timed up and Go test, Action Research Arm Test

Health economic measures:

Length of initial stay, Hospital readmissions, stroke recurrence, mortality, Prescription use, GP visits, Level of paid social care STUDY DESIGN and METHODS of DATA COLLECTION AND DATA ANALYIS This is a phase 2, Pre-post design with a non-equivalent virtual control group (VCG) from data linkage study in line with Medical Research Council recommendations for development of a complex intervention.

  • Inpatients on the stroke unit at University Hospital Wishaw will be assessed for broad eligibility by the NHS multidisciplinary team using the inclusion/exclusion criteria.
  • Patients who have been identified as medically fit for rehabilitation and who fit the criteria for the study shall be highlighted to the research assistant by the NHS medical/therapy team. The researcher shall then check with the relevant members of the multi-disciplinary team that all inclusion/exclusion criteria are met before approaching the patient.
  • The Participant Information Sheet with info on the study shall be supplied to the patient by the research assistant and an opportunity shall be offered for any questions from the patient and their family/carers if appropriate, with the patients consent. Informed consent shall then be taken by a University of Strathclyde research assistant only.
  • Participants will be supported to access and use the rehabilitation technology, in addition to usual care, by NHS staff. This will involve the prescription of a rehabilitation technology programme by the ward NHS physiotherapists, occupational therapists and speech and language therapists, following usual care assessment. This is with an aim to increase rehabilitation activity within the participant's capacity, taking into account their level of impairment and fatigue. Therefore, time spent using the rehabilitation technology will be varied and tailored to meet the participant's needs. The dose and intensity of technology enriched rehabilitation will be measured and recorded, however will not be controlled for these reasons.
  • The Principal Investigator (NHS occupational therapist) will hold weekly meetings with the ward therapy staff to discuss any concerns around the study or regarding participant programs and will liaise directly with the research assistant as appropriate.
  • Data collection/outcome measures will be completed as follows; Measures of recruitment and adherence Levels of recruitment (percentage of eligible individual consenting to participate) and attrition (percentage of people dropping/opting out before discharge) will be monitored and collated by the research assistant.

Duration spent on activities within the 'technology enriched rehabilitation space' will be timed by the NHS staff supporting the participants within the room, and these will be collated by the research assistant.

Additional outcome measures In order to further inform future studies the research team will collate the scores of the standard care

  • Any Serious Adverse Effects (SAE) should be reported immediately to the Principal Investigator and a report made
  • Participants' involvement in the study will end upon discharge from the stroke unit, or if withdrawn from the study for medical reasons or by personal choice.

Sample size Sample size / detectable difference. For a between-group difference of 1.6 points on the 15-point Rivermead Mobility Index (SD 3.0) (GAPS Study, Glasgow Augmented Physiotherapy Study (GAPS) group, 2004) with α = 0.05 and 80% power, the study requires ≈56 participants per group. Allowing for 10% attrition, the recruitment target of 62 participants per group is considered sufficient. The previous feasibility study recruited 60 participants over 9 months, a similar target is therefore regarded as achievable. A larger sample size for the virtual group (matched on diagnosis, age and Heath Board area) is planned (n=150) to improve statistical power. This would give a total sample of 212.

Data Analysis Analysis will be completed by the research team at the University of Strathclyde.

This pilot efficacy study will test the superiority of technology enriched rehabilitation over usual care by comparing the primary outcome measure (mRMI).

Exploratory analysis of other outcome measures of balance, upper limb function and walking recorded from the sample at UHW will be used to understand change in the primary variable (mRMI).

02

Conditions studied

  • Stroke
  • Rehabilitation

Browse trials for

Keywords

  • Rehabilitation
  • Technology
  • Stroke
03

In context

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

This study's planned enrollment of 62 is above the median of 48 across 6,049 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Strathclyde is the lead sponsor of 20 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of new stroke by NHS Lanarkshire physician
  • More than 48 hours since stroke event
  • Deemed medically fit for rehabilitation by medical staff
  • Deemed to require rehabilitation
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Acutely medically unwell
  • Active cardiac disease, such as unstable angina
  • Active delirium/significant levels of confusion
  • Seizure within past 7 days
  • Individual currently being managed under the Adults with Incapacity Act, unless the responsible medic has noted within the document that the individual has capacity to consent to rehabilitation research
  • Known pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Technology Enriched Rehabilitation

    The intervention is a rehabilitation programme delivered entirely through technology, including virtual reality (immersed and non-immersed), treadmills, weight suspension and movement resistance, and power assistance equipment located in a gym-like space located on an acute stroke unit. Individual programs are designed and reviewed by a physiotherapist using principles of intensity, feedback, cognitive engagement, and aerobic activity to address the goals identified by the participant and scores from outcome measures at baseline. Supervision is provided by rehabilitation assistants Participants attend according to their tolerance (assessed by clinical team) up to 2 hours per day until discharged home.

    Other: Technology Enriched Rehabilitation

Interventions

  • OtherTechnology Enriched Rehabilitation

    The intervention is a rehabilitation programme delivered entirely through technology, including virtual reality (immersed and non-immersed), treadmills, weight suspension and movement resistance, and power assistance equipment located in a gym-like space on an acute stroke unit (NHS Lanarkshire). Individual programs are designed and reviewed by a physiotherapist using principles of intensity, feedback, cognitive engagement, and aerobic activity to address the goals identified by the participant and scores from outcome measures at baseline. Attendance at the gym is supervised and assisted by rehabilitation support workers. Participants can attend daily for 2 hours maximum until discharge, according to their tolerance and judgement of the clinical ward team.

06

What researchers measure

Primary outcomes

  1. Modified Rivermead Mobility Index (MRMI)

    The Modified Rivermead Mobility Index (MRMI) is a standardized 8-item assessment that evaluates mobility tasks including turning over, balance, transfers, walking, and stair climbing. Scores range from 0 to 40, with higher scores indicating greater mobility. The items include: Turning over Lying to sitting Sitting balance Sitting to standing Standing Transfers Walking indoors Stairs

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

Secondary outcomes

  1. 10-Metre Walk Test (10MWT)

    A standardized assessment of gait speed over a 10-metre distance. Faster times indicate better walking ability.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  2. Five Times Sit-to-Stand Test (FTSTST)

    A functional lower-limb strength and mobility test measuring the time required to stand up from a seated position five times. Shorter times indicate better performance.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  3. Berg Balance Scale (BBS)

    A 14-item scale assessing static and dynamic balance. Scores range from 0 to 56, with higher scores indicating better balance.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  4. Action Research Arm Test (ARAT)

    A standardized 19-item measure of upper-limb function assessing grasp, grip, pinch, and gross arm movement. Scores range from 0 to 57; higher scores indicate better arm function.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  5. Grip Strength

    Maximum isometric grip force measured using a dynamometer. Higher values indicate greater strength.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  6. Therapy Outcome Measure (TOM)

    A multidimensional clinical scale capturing impairment, activity, participation, and well-being

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  7. Fatigue Assessment Scale (FAS)

    A 10-item questionnaire evaluating physical and mental fatigue. Scores range from 10 to 50, with higher scores indicating more severe fatigue.

    Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.

  8. Length of Initial Hospital Stay

    Total number of days from hospital admission to discharge.

    Time frame: Through completion of the initial hospital stay.

  9. Hospital Readmissions

    Number of unplanned readmissions to any hospital setting.

    Time frame: Through study completion and up to 12 months post hospital discharge.

  10. Stroke Recurrence

    Number of clinically confirmed recurrent strokes.

    Time frame: Through study completion and up to 12 months post hospital discharge.

  11. Prescription Use

    Number and type of prescribed medications captured from medical records.

    Time frame: Through study completion and up to 12 months post hospital discharge.

  12. Ongoing Rehabilitation Use

    Use (number of sessions) of outpatient or community-based rehabilitation services following discharge.

    Time frame: Through study completion and up to 12 months post hospital discharge.

  13. GP Visits

    Number of visits to primary care providers during the follow-up period.

    Time frame: Through study completion and up to 12 months post hospital discharge.

  14. Level of Paid Social Care

    Amount and type of paid social care support used by participants (e.g., home care hours).

    Time frame: Through study completion and up to 12 months post hospital discharge

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kerr A, Keogh M, Slachetka M, Grealy M, Rowe P. An Intensive Exercise Program Using a Technology-Enriched Rehabilitation Gym for the Recovery of Function in People With Chronic Stroke: Usability Study. JMIR Rehabil Assist Technol. 2023 Jul 21;10:e46619. doi: 10.2196/46619. PubMed 37477954 ↗
  • Sweeney G, Boyd F, Keogh M, Lyczba P, Forrest E, Rowe P, Barber M, Kerr A. A technology-enriched approach to increasing rehabilitation dose after stroke: Clinical feasibility study. Clin Rehabil. 2025 Jun;39(6):740-749. doi: 10.1177/02692155251333542. Epub 2025 Apr 18. PubMed 40247700 ↗
  • Gittins M, Vail A, Bowen A, Lugo-Palacios D, Paley L, Bray B, Gannon B, Tyson S. Factors influencing the amount of therapy received during inpatient stroke care: an analysis of data from the UK Sentinel Stroke National Audit Programme. Clin Rehabil. 2020 Jul;34(7):981-991. doi: 10.1177/0269215520927454. Epub 2020 Jun 7. PubMed 32508132 ↗

Individual participant data

Plan to share: Yes — Data will be posted on the University's Data Sharing repository (PURE)

Supporting information: Study protocol, Clinical study report

Time frame: July 2027 Until July 2032

Access criteria: This will be publicly available

Data sharing details ↗ · www.strath.ac.uk

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Jun 2027, 14 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 14 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2025
First posted
Jan 22, 2026
StartEst.
Apr 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jul 2028
Last update
Jan 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07360613
Lead sponsor
University of Strathclyde
Collaborators
NHS Lanarkshire
Responsible party
Sponsor
First posted
Jan 22, 2026
Start date
Apr 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jan 22, 2026

Study contacts

Andrew Kerr, PhD
Contact
a.kerr@strath.ac.uk
+441415482855 ext. +441415482855
Lesley-Anne Rollins, PhD
Contact
lesleyanne.rollins@strath.ac.uk
Andrew Kerr
study director · Strathclyde
Gillian Sweeney, PhD
principal investigator · NHS Lanarkshire

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion